S-Bank Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$904K Buy
15,694
+783
+5% +$45K 0.12% 104
2026
Q1
$904K Sell
14,911
-554
-4% -$32.3K 0.13% 99
2025
Q4
$834K Sell
15,465
-8,286
-35% -$399K 0.11% 101
2025
Q3
$1.07M Sell
23,751
-310
-1% -$14.5K 0.14% 96
2025
Q2
$1.11M Sell
24,061
-83,435
-78% -$4.1M 0.16% 96
2025
Q1
$6.56M Buy
+107,496
New +$6.27M 1.23% 25

Other funds holding BMY

S-Bank Fund Management's BMY Position: Q2 2026 in Review

S-Bank Fund Management increased its Bristol-Myers Squibb (BMY) stake by 5.3% in Q2 2026, buying an estimated $45K and bringing the position to 15,694 shares worth $904K. The position accounts for 0.12% of the portfolio, ranked #104.

S-Bank Fund Management first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.56M in Q1 2025. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • S-Bank Fund Management held 15,694 shares of Bristol-Myers Squibb worth $904K as of Q2 2026.
  • S-Bank Fund Management bought 783 Bristol-Myers Squibb shares in Q2 2026, an estimated $45K.
  • Bristol-Myers Squibb made up 0.12% of S-Bank Fund Management's portfolio in Q2 2026, its #104 holding.
  • S-Bank Fund Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
  • S-Bank Fund Management's Bristol-Myers Squibb position peaked at $6.56M in Q1 2025.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.